{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:00:22Z","timestamp":1792206022057,"version":"4.4.0"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["W81XWH-21-1-0894"],"award-info":[{"award-number":["W81XWH-21-1-0894"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["W81XWH-21-1-0932"],"award-info":[{"award-number":["W81XWH-21-1-0932"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.addr.2024.115429","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T01:38:03Z","timestamp":1723513083000},"page":"115429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap"],"prefix":"10.1016","volume":"213","author":[{"given":"Afsana","family":"Naaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heth R.","family":"Turnquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay S.","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2024.115429_b0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.addr.2024.115429_b0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21(st) century","author":"Black","year":"2018","journal-title":"Ann Transl Med 6"},{"key":"10.1016\/j.addr.2024.115429_b0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014985","article-title":"Why is organ transplantation clinically important?","volume":"3","author":"Griny\u00f3","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.addr.2024.115429_b0020","series-title":"Vascular composite allografts (VCA): new transplants, new infections BT - emerging transplant infections: Clinical challenges and implications","first-page":"1","author":"Steinbrink","year":"2020"},{"key":"10.1016\/j.addr.2024.115429_b0025","first-page":"1569","article-title":"The research landscape on vascularized composite allografts: a bibliometric analysis (2002\u20132021)","volume":"15","author":"Sun","year":"2023","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.addr.2024.115429_b0030","doi-asserted-by":"crossref","first-page":"S523","DOI":"10.1016\/j.ajt.2023.02.012","article-title":"OPTN\/SRTR 2021 annual data report: Vascularized composite allograft","volume":"23","author":"Hernandez","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0035","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: Current perspectives","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s002680010124","article-title":"History of clinical transplantation","volume":"24","author":"Starzl","year":"2000","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"10.1016\/j.addr.2024.115429_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13199","article-title":"OPTN\/SRTR 2013 Annual data report: heart","volume":"15","author":"Colvin-Adams","year":"2015","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.addr.2024.115429_b0050","article-title":"OPTN\/SRTR 2013 Annual data report: liver","volume":"15","author":"Kim","year":"2015","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.addr.2024.115429_b0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/ajt.12024","article-title":"OPTN\/SRTR 2011 annual data report: lung","volume":"13","author":"Valapour","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2024.115429_b0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994\u20132004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-6143.2006.01611.x","article-title":"Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients","volume":"7","author":"Denhaerynck","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115429_b0080","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/ckj\/sfac017","article-title":"Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation","volume":"15","author":"Gandolfini","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.addr.2024.115429_b0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40472-016-0113-x","article-title":"Vascularized composite allotransplantation: Medical complications","volume":"3","author":"Uluer","year":"2016","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.addr.2024.115429_b0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00006534-199103000-00001","article-title":"Relative antigenicity of components of a vascularized limb allograft","volume":"87","author":"Lee","year":"1991","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.addr.2024.115429_b0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bjps.2023.09.043","article-title":"18 years of face transplantation: Adverse outcomes and challenges","volume":"87","author":"Longo","year":"2023","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.addr.2024.115429_b0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015651","article-title":"Facial and hand allotransplantation","volume":"4","author":"Pomahac","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.addr.2024.115429_b0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/ajt.16219","article-title":"Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients","volume":"21","author":"Ito","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0110","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1111\/ajt.16164","article-title":"Extracellular vesicles for treatment of solid organ ischemia-reperfusion injury","volume":"20","author":"Ali","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0115","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.17012","article-title":"Nanotherapeutics in transplantation: How do we get to clinical implementation?","volume":"22","author":"Plumblee","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0120","doi-asserted-by":"crossref","first-page":"eaam6764","DOI":"10.1126\/scitranslmed.aam6764","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys","author":"Tietjen","year":"2017","journal-title":"Sci Transl Med 9"},{"key":"10.1016\/j.addr.2024.115429_b0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.08.009","article-title":"Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival","volume":"156","author":"Dane","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_b0130","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1172\/JCI120923","article-title":"Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival","volume":"128","author":"Bahmani","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2024.115429_b0135","doi-asserted-by":"crossref","first-page":"17124","DOI":"10.1021\/acsnano.1c04707","article-title":"Intra-organ delivery of nanotherapeutics for organ transplantation","volume":"15","author":"Hussain","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115429_b0140","first-page":"eaax8429","article-title":"In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation","author":"Fisher","year":"2024","journal-title":"Sci Adv 6"},{"key":"10.1016\/j.addr.2024.115429_b0145","first-page":"eaax8429","article-title":"In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation","author":"Fisher","year":"2023","journal-title":"Sci Adv 6"},{"key":"10.1016\/j.addr.2024.115429_b0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.addr.2024.115429_b0155","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2217\/nnm-2019-0137","article-title":"Biomaterials for topical and transdermal drug delivery in reconstructive transplantation","volume":"14","author":"Dhayani","year":"2019","journal-title":"Nanomedicine (lond)"},{"key":"10.1016\/j.addr.2024.115429_b0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MOT.0000000000000564","article-title":"Novel targeted drug delivery systems to minimize systemic immunosuppression in vascularized composite allotransplantation","volume":"23","author":"Taddeo","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0165","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001100","article-title":"The emerging role of nanotechnology in cell and organ transplantation","volume":"100","author":"Tasciotti","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0170","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1152\/ajpendo.00310.2021","article-title":"Considerations and challenges of islet transplantation and future therapies on the horizon","volume":"322","author":"Walker","year":"2021","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.addr.2024.115429_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major Histocompatibility Complex (MHC) class I and MHC class ii proteins: conformational plasticity in antigen presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0180","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/TP.0000000000003169","article-title":"Memory T cells in transplantation: old challenges define new directions","volume":"104","author":"Nicosia","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0185","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000004572","article-title":"An immune atlas of T cells in transplant rejection: Pathways and therapeutic opportunities","volume":"107","author":"Short","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582939","article-title":"Macrophages in organ transplantation","volume":"11","author":"Ordikhani","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895157","article-title":"B-cell response in solid organ transplantation","volume":"13","author":"Yi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081852","article-title":"Mesenchymal stem\/stromal cells for rheumatoid arthritis treatment: An update on clinical applications","volume":"9","author":"Lopez-Santalla","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.addr.2024.115429_b0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13619-020-00058-0","article-title":"Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives","volume":"9","author":"Abedi","year":"2020","journal-title":"Cell Regeneration"},{"key":"10.1016\/j.addr.2024.115429_b0210","doi-asserted-by":"crossref","first-page":"6951693","DOI":"10.1155\/2016\/6951693","article-title":"Immunomodulatory role of mesenchymal stem cell therapy in vascularized composite allotransplantation","volume":"2016","author":"Heyes","year":"2016","journal-title":"J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249683","article-title":"The anti-inflammatory properties of mesenchymal stem cells in epilepsy: Possible treatments and future perspectives","volume":"21","author":"Salari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addr.2024.115429_b0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/cmi.2014.52","article-title":"Tolerogenic dendritic cells and their applications in transplantation","volume":"12","author":"Li","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0225","first-page":"152","article-title":"Generation and function of induced regulatory T cells","author":"Schmitt","year":"2013","journal-title":"Front Immunol 4"},{"key":"10.1016\/j.addr.2024.115429_b0230","doi-asserted-by":"crossref","first-page":"e31465","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of na\u00efve T cells into cytokine-producing mature T cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115429_b0235","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.transproceed.2005.08.040","article-title":"Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients","volume":"37","author":"Abou-Jaoude","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.addr.2024.115429_b0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity-what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.addr.2024.115429_b0245","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"2","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2024.115429_b0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: A review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.addr.2024.115429_b0255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00003495-200767030-00004","article-title":"Use of sirolimus in solid organ transplantation","volume":"67","author":"Augustine","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2024.115429_b0260","first-page":"479","article-title":"The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy","volume":"10","author":"Janus","year":"2005","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.addr.2024.115429_b0265","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2002-11-3370","article-title":"Rapamycin inhibits IL-4\u2013induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo","volume":"101","author":"Hackstein","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2024.115429_b0270","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil","volume":"75","author":"van Gelder","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0275","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000186390.10150.66","article-title":"Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection","volume":"80","author":"Allison","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0280","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jcph.1064","article-title":"Mycophenolic acid and its metabolites in kidney transplant recipients: A semimechanistic enterohepatic circulation model to improve estimating exposure","volume":"58","author":"Okour","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.addr.2024.115429_b0285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.11.004","article-title":"Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages","volume":"114","author":"Jiang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115429_b0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: Mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.addr.2024.115429_b0300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4161\/mabs.2.2.11159","article-title":"Antibody immunosuppressive therapy in solid-organ transplant: Part I","volume":"2","author":"Mahmud","year":"2010","journal-title":"Mabs"},{"key":"10.1016\/j.addr.2024.115429_b0305","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/ajt.15342","article-title":"Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation","volume":"19","author":"Alloway","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115429_b0310","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2024.115429_b0315","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.1100713","article-title":"Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells","volume":"187","author":"Penaranda","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0320","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40262-017-0573-x","article-title":"Review of the clinical pharmacokinetics and pharmacodynamics of alemtuzumab and its use in kidney transplantation","volume":"57","author":"van der Zwan","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.addr.2024.115429_b0325","first-page":"3500","article-title":"Is CD25 blockade optimal in kidney transplant patients treated with basiliximab?","volume":"88","author":"Le Tilly","year":"2022","journal-title":"A Target-Mediated Drug Disposition Model, Br J Clin Pharmacol"},{"key":"10.1016\/j.addr.2024.115429_b0330","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.transproceed.2019.02.051","article-title":"Effect of rabbit antithymocyte globulin on acute and chronic active antibody-mediated rejection after kidney transplantation","volume":"51","author":"Nanmoku","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.addr.2024.115429_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03100","article-title":"Treg heterogeneity, function, and homeostasis","volume":"10","author":"Shevyrev","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.746889","article-title":"Utilization of treg cells in solid organ transplantation","volume":"13","author":"Juneja","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0345","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2024.115429_b0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.addr.2024.115429_b0355","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.1900733","article-title":"Low-dose IL-2 therapy in transplantation, autoimmunity, and inflammatory diseases","volume":"203","author":"Tahvildari","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2024.115429_b0360","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2022.08.035","article-title":"Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans","volume":"78","author":"Lim","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.addr.2024.115429_b0370","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","volume":"13","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.addr.2024.115429_b0375","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/IJNRD.S88816","article-title":"Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy","volume":"9","author":"Hardinger","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.addr.2024.115429_b0380","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/TP.0b013e3181fe1377","article-title":"Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade","volume":"90","author":"Posselt","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1167975","article-title":"Immune-related adverse events of immune checkpoint inhibitors: a review","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115429_b0390","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000004469","article-title":"CD40-CD40L blockade: Update on novel investigational therapeutics for transplantation","volume":"107","author":"Singh","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0395","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.18632\/oncotarget.13895","article-title":"PD-1 and its ligands are important immune checkpoints in cancer","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2024.115429_b0400","doi-asserted-by":"crossref","first-page":"1227756","DOI":"10.3389\/fimmu.2023.1227756","article-title":"Progress of PD-1\/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma","volume":"14","author":"Ju","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0405","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2024.115429_b0410","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/tri.14163","article-title":"Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation","volume":"34","author":"Bergstr\u00f6m","year":"2021","journal-title":"Transpl. Int."},{"key":"10.1016\/j.addr.2024.115429_b0415","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.addr.2024.115429_b0420","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.addr.2024.115429_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110727","article-title":"Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses","volume":"39","author":"Saxena","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.addr.2024.115429_b0430","doi-asserted-by":"crossref","first-page":"25784","DOI":"10.1073\/pnas.1910701116","article-title":"Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation","volume":"116","author":"Fisher","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2024.115429_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040791","article-title":"Mesenchymal stem\/stromal cells in organ transplantation","volume":"14","author":"Deo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_b0440","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/sctm.18-0033","article-title":"Using mesenchymal stromal cells in islet transplantation","volume":"7","author":"Arzouni","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.addr.2024.115429_b0445","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3389\/fimmu.2018.02666","article-title":"Third-party allogeneic mesenchymal stromal cells prevent rejection in a pre-sensitized high-risk model of corneal transplantation","volume":"9","author":"Lohan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0450","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","article-title":"Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation","volume":"12","author":"Casiraghi","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0455","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1401776","article-title":"Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy","volume":"193","author":"Obermajer","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00350","article-title":"Mechanisms of tolerance induction by dendritic cells in vivo","volume":"9","author":"Hasegawa","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115429_b0465","doi-asserted-by":"crossref","first-page":"e1632","DOI":"10.1002\/wnan.1632","article-title":"Advances in engineering local drug delivery systems for cancer immunotherapy","volume":"12","author":"Abdou","year":"2020","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.addr.2024.115429_b0470","doi-asserted-by":"crossref","first-page":"2202238","DOI":"10.1002\/adhm.202202238","article-title":"Tissue-targeted drug delivery strategies to promote antigen-specific immune tolerance","volume":"12","author":"Rui","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2024.115429_b0475","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102244","article-title":"Immunomodulating hydrogels as stealth platform for drug delivery applications","volume":"14","author":"Rezaei","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_b0480","article-title":"Nanoparticle-based drug delivery systems for induction of tolerance and treatment of autoimmune diseases","volume":"10","author":"Li","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.addr.2024.115429_b0485","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bit.21301","article-title":"Microparticles and nanoparticles for drug delivery","volume":"96","author":"Kohane","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.addr.2024.115429_b0490","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2012.10.003","article-title":"Advanced materials and processing for drug delivery: the past and the future","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115429_b0495","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.addr.2024.115429_b0500","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.addr.2024.115429_b0505","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm87030020","article-title":"Microparticles, microspheres, and microcapsules for advanced drug delivery","volume":"87","author":"Lengyel","year":"2019","journal-title":"Sci Pharm"},{"key":"10.1016\/j.addr.2024.115429_b0510","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2015.04.013","article-title":"Micro and nanoparticle drug delivery systems for preventing allotransplant rejection","volume":"160","author":"Fisher","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0515","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1021\/nl102184c","article-title":"Nanotechnology in drug delivery and tissue engineering: from discovery to applications","volume":"10","author":"Shi","year":"2010","journal-title":"Nano Lett"},{"key":"10.1016\/j.addr.2024.115429_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113971","article-title":"Local delivery strategies to restore immune homeostasis in the context of inflammation","volume":"178","author":"Bentley","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115429_b0525","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17425247.2022.2076834","article-title":"Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation","volume":"19","author":"Campa-Carranza","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.addr.2024.115429_b0530","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.800018","article-title":"Extracellular vesicles in transplantation","volume":"13","author":"Sailliet","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115429_b0535","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.kint.2021.10.038","article-title":"Extracellular vesicles in kidney transplantation: a state-of-the-art review","volume":"101","author":"Ashcroft","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.addr.2024.115429_b0540","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030891","article-title":"Extracellular vesicles as drug delivery systems in organ transplantation: The next frontier","volume":"15","author":"Spiers","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_b0545","doi-asserted-by":"crossref","DOI":"10.3390\/polym15071596","article-title":"Nanoparticles as drug delivery systems: A review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems","volume":"15","author":"Yusuf","year":"2023","journal-title":"Polymers (basel)."},{"key":"10.1016\/j.addr.2024.115429_b0550","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jconrel.2013.09.028","article-title":"Leveraging nanochannels for universal, zero-order drug delivery in vivo","volume":"172","author":"Ferrati","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_b0555","first-page":"1117","article-title":"Nanotoxicology and nanoparticle safety in biomedical designs","volume":"6","author":"Ai","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.addr.2024.115429_b0560","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0041-1345(98)01923-X","article-title":"Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity","volume":"31","author":"McAlister","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.addr.2024.115429_b0565","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3727\/000000004783983936","article-title":"Liposomal formulations of tacrolimus and rapamycin increase graft survival and fiber outgrowth of dopaminergic grafts","volume":"13","author":"Alemdar","year":"2004","journal-title":"Cell Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0570","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/00007890-198905000-00012","article-title":"The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients","volume":"47","author":"Flechner","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0575","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030774","article-title":"Approved nanomedicine against diseases","volume":"15","author":"Jia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_b0580","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: An update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.addr.2024.115429_b0585","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.nano.2009.02.002","article-title":"PEGylated PLGA nanoparticles for the improved delivery of doxorubicin","volume":"5","author":"Park","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2024.115429_b0590","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jps.21406","article-title":"Zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells","volume":"98","author":"Mainardes","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.addr.2024.115429_b0595","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2009.10.004","article-title":"Gelatin nanocarriers as potential vectors for effective management of tuberculosis","volume":"385","author":"Saraogi","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2024.115429_b0600","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","article-title":"Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency","volume":"70","author":"Mao","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_b0605","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1021\/nn404501g","article-title":"Facing the truth about nanotechnology in drug delivery","volume":"7","author":"Park","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115429_b0610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/mp100203a","article-title":"Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery","volume":"8","author":"Park","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.addr.2024.115429_b0615","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1096\/fj.10-154690","article-title":"Polylactide-cyclosporin A nanoparticles for targeted immunosuppression","volume":"24","author":"Azzi","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2024.115429_b0620","doi-asserted-by":"crossref","first-page":"25909","DOI":"10.1039\/C8RA01555D","article-title":"Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo","volume":"8","author":"Zhu","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.addr.2024.115429_b0625","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.1021\/acs.langmuir.8b02946","article-title":"Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy","volume":"34","author":"Clemons","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2024.115429_b0630","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40204-020-00139-y","article-title":"Recent advances in the formulation of PLGA microparticles for controlled drug delivery","volume":"9","author":"Lagreca","year":"2020","journal-title":"Prog Biomater"},{"key":"10.1016\/j.addr.2024.115429_b0635","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12265-011-9291-1","article-title":"Injectable acellular hydrogels for cardiac repair","volume":"4","author":"Tous","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.addr.2024.115429_b0640","article-title":"Hydrogels based drug delivery synthesis","volume":"11","author":"Onaciu","year":"2019","journal-title":"Characterization and Administration., Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_b0645","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.05.034","article-title":"Amphiphilic polyurethane hydrogels as smart carriers for acidic hydrophobic drugs","volume":"546","author":"Polo Fonseca","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2024.115429_b0650","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2015.12.004","article-title":"To serve and protect: Hydrogels to improve stem cell-based therapies","volume":"18","author":"Burdick","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2024.115429_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110702","article-title":"Injectable hydrogel-based drug delivery system for cartilage regeneration","volume":"110","author":"Garc\u00eda-Fern\u00e1ndez","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.addr.2024.115429_b0660","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2019.05.028","article-title":"Growth factor delivery: Defining the next generation platforms for tissue engineering","volume":"306","author":"Caballero Aguilar","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_b0665","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.msec.2017.09.003","article-title":"Influence of alginate backbone on efficacy of thermo-responsive alginate-g-P(NIPAAm) hydrogel as a vehicle for sustained and controlled gene delivery","volume":"95","author":"Chalanqui","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.addr.2024.115429_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.115920","article-title":"Formation of self-assembled polyelectrolyte complex hydrogel derived from salecan and chitosan for sustained release of Vitamin C","volume":"234","author":"Hu","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.addr.2024.115429_b0675","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijbiomac.2019.09.013","article-title":"Drug release and kinetic models of anticancer drug (BTZ) from a pH-responsive alginate polydopamine hydrogel: Towards cancer chemotherapy","volume":"141","author":"Rezk","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2024.115429_b0680","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.RES.0000126411.29641.08","article-title":"Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth","volume":"94","author":"Ehrbar","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.addr.2024.115429_b0685","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijbiomac.2020.01.227","article-title":"Hydrophobically-modified gelatin hydrogel as a carrier for charged hydrophilic drugs and hydrophobic drugs","volume":"149","author":"Takei","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2024.115429_b0690","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.carbpol.2018.05.004","article-title":"Effect of freeze-thawing conditions for preparation of chitosan-poly (vinyl alcohol) hydrogels and drug release studies","volume":"195","author":"Figueroa-Pizano","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.addr.2024.115429_b0695","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nprot.2016.037","article-title":"Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms","volume":"11","author":"Loessner","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.addr.2024.115429_b0700","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biotechadv.2017.05.006","article-title":"Biocompatibility of hydrogel-based scaffolds for tissue engineering applications","volume":"35","author":"Naahidi","year":"2017","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.addr.2024.115429_b0705","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.addr.2024.115429_b0710","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0169-409X(01)00203-4","article-title":"Environment-sensitive hydrogels for drug delivery","volume":"53","author":"Qiu","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115429_b0715","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1081\/DDC-120006428","article-title":"Stimulus-responsive \u201csmart\u201d hydrogels as novel drug delivery systems","volume":"28","author":"Soppimath","year":"2002","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.addr.2024.115429_b0720","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbm.a.34132","article-title":"Antimicrobial peptide incorporated poly(2-hydroxyethyl methacrylate) hydrogels for the prevention of Staphylococcus epidermidis-associated biomaterial infections","volume":"100","author":"Laverty","year":"2012","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.addr.2024.115429_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymer.2019.121994","article-title":"Preparation of printable double-network hydrogels with rapid self-healing and high elasticity based on hyaluronic acid for controlled drug release","volume":"186","author":"Qiao","year":"2020","journal-title":"Polymer (guildf)"},{"key":"10.1016\/j.addr.2024.115429_b0730","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat Mater"},{"key":"10.1016\/j.addr.2024.115429_b0735","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fbioe.2020.00228","article-title":"Hydrogel biomaterials for application in ocular drug delivery","volume":"8","author":"Lynch","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.addr.2024.115429_b0740","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/00914037.2020.1740989","article-title":"An overview of hydrogels and their role in transdermal drug delivery","volume":"70","author":"Ahsan","year":"2021","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.addr.2024.115429_b0745","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2018.03.034","article-title":"Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury","volume":"278","author":"Papa","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115429_b0750","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.actbio.2018.02.019","article-title":"Exogenous stromal derived factor-1 releasing silk scaffold combined with intra-articular injection of progenitor cells promotes bone-ligament-bone regeneration","volume":"71","author":"Hu","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.addr.2024.115429_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114950","article-title":"Solid implantable devices for sustained drug delivery","volume":"199","author":"Magill","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115429_b0760","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/anie.201700153","article-title":"Control of nanoparticle release kinetics from 3D printed hydrogel scaffolds","volume":"56","author":"Baumann","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2024.115429_b0765","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.msec.2014.12.039","article-title":"Controlled release of doxorubicin from electrospun PEO\/chitosan\/graphene oxide nanocomposite nanofibrous scaffolds","volume":"48","author":"Ardeshirzadeh","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2024.115429_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.109621","article-title":"Polymer scaffolds as drug delivery systems","author":"Calori","year":"2020","journal-title":"Eur Polym J 129"},{"key":"10.1016\/j.addr.2024.115429_b0775","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41578-019-0150-z","article-title":"Design of biodegradable, implantable devices towards clinical translation","volume":"5","author":"Li","year":"2020","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.addr.2024.115429_b0780","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003226-200110000-00015","article-title":"Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer","volume":"20","author":"Xie","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2024.115429_b0785","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00417-010-1388-8","article-title":"Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial","volume":"248","author":"Sinha","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.addr.2024.115429_b0790","first-page":"1461","article-title":"Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats","volume":"12","author":"Bourges","year":"2006","journal-title":"Mol vis"},{"key":"10.1016\/j.addr.2024.115429_b0795","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/02713680500320752","article-title":"FK506 in a biodegradable glycolide-co-clatide-co-caprolactone polymer for prolongation of corneal allograft survival","volume":"30","author":"Shi","year":"2005","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.addr.2024.115429_b0800","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1167\/iovs.05-1425","article-title":"Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits","volume":"47","author":"Shi","year":"2006","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.addr.2024.115429_b0805","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ophtha.2012.09.035","article-title":"A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study","volume":"120","author":"Shi","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2024.115429_b0810","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2011.03503.x","article-title":"Bilateral trans-humeral arm transplantation: result at 2 years","volume":"11","author":"Cavadas","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0815","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/TP.0b013e3181ff1472","article-title":"The international registry on hand and composite tissue transplantation","volume":"90","author":"Petruzzo","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0820","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00007890-198911000-00011","article-title":"Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival","volume":"48","author":"Arai","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0825","doi-asserted-by":"crossref","first-page":"403e","DOI":"10.1097\/PRS.0000000000002951","article-title":"Single implantable FK506 disk prevents rejection in vascularized composite Allotransplantation","volume":"139","author":"Unadkat","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.addr.2024.115429_b0830","first-page":"249ra110","article-title":"A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft","author":"Gajanayake","year":"2014","journal-title":"Sci Transl Med 6"},{"key":"10.1016\/j.addr.2024.115429_b0835","doi-asserted-by":"crossref","first-page":"e0203409","DOI":"10.1371\/journal.pone.0203409","article-title":"Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging","volume":"13","author":"Dzhonova","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115429_b0840","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/TP.0000000000002283","article-title":"Local injections of tacrolimus-loaded hydrogel reduce systemic immunosuppression-related toxicity in vascularized composite allotransplantation","volume":"102","author":"Dzhonova","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b0845","doi-asserted-by":"crossref","first-page":"e0210914","DOI":"10.1371\/journal.pone.0210914","article-title":"Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study","volume":"14","author":"Fries","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115429_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120232","article-title":"Neovascularized implantable cell homing encapsulation platform with tunable local immunosuppressant delivery for allogeneic cell transplantation","author":"Paez-Mayorga","year":"2020","journal-title":"Biomaterials 257"},{"key":"10.1016\/j.addr.2024.115429_b0855","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1038\/s41467-022-35629-z","article-title":"Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats","volume":"13","author":"Paez-Mayorga","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2024.115429_b0860","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nature Reviews Bioengineering"},{"key":"10.1016\/j.addr.2024.115429_b0865","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.addr.2024.115429_b0870","doi-asserted-by":"crossref","first-page":"2000544","DOI":"10.1002\/adfm.202000544","article-title":"Encapsulation of human natural and induced regulatory T-cells in IL-2 and CCL1 supplemented alginate-GelMA hydrogel for 3D bioprinting","volume":"30","author":"Kim","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.addr.2024.115429_b0875","doi-asserted-by":"crossref","first-page":"34883","DOI":"10.1074\/jbc.M111.276329","article-title":"An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response","volume":"286","author":"Steenblock","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.addr.2024.115429_b0880","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2015.04.003","article-title":"Paracrine co-delivery of TGF-\u03b2 and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells","volume":"59","author":"McHugh","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115429_b0885","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1038\/s41598-019-42349-w","article-title":"Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival","volume":"9","author":"Uehara","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2024.115429_b0890","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/pj.2013.71","article-title":"The graft survival protection of subcutaneous allogeneic islets with hydrogel grafting and encapsulated by CTLA4Ig and IL1ra","volume":"46","author":"Hou","year":"2014","journal-title":"Polym J"},{"key":"10.1016\/j.addr.2024.115429_b0895","doi-asserted-by":"crossref","first-page":"eaba5573","DOI":"10.1126\/sciadv.aba5573","article-title":"Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival","author":"Coronel","year":"2020","journal-title":"Sci Adv 6"},{"key":"10.1016\/j.addr.2024.115429_b0900","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.2147\/OTT.S221340","article-title":"The role Of PD-1\/PD-L1 axis in treg development and function: implications for cancer immunotherapy","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.addr.2024.115429_b0905","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-017-9717-6","article-title":"RNA interference-based therapy and its delivery systems","volume":"37","author":"Chen","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.addr.2024.115429_b0910","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.15689","article-title":"RNA interference therapeutics in organ transplantation: The dawn of a new era","volume":"20","author":"Br\u00fcggenwirth","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115429_b0915","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.173.7.4331","article-title":"Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells","volume":"173","author":"Machen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.addr.2024.115429_b0920","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41467-017-00297-x","article-title":"Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells","volume":"8","author":"Cui","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2024.115429_b0925","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1248\/bpb.19.1527","article-title":"Lymphotropic delivery of cyclosporin A by intramuscular injection of biodegradable microspheres in mice","volume":"19","author":"Yoshikawa","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.addr.2024.115429_b0930","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1080\/10717544.2021.1968978","article-title":"Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection","volume":"28","author":"Deng","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.addr.2024.115429_b0935","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/jphp.12430","article-title":"Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting","volume":"67","author":"Mistry","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.addr.2024.115429_b0940","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1063\/1.3587467","article-title":"Application of biodegradable nanoparticles in liver targeting of tacrolimus","volume":"1326","author":"Affifi","year":"2011","journal-title":"AIP Conference Proceedings"},{"key":"10.1016\/j.addr.2024.115429_b0945","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41565-021-01048-2","article-title":"Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability","volume":"17","author":"Burke","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.addr.2024.115429_b0950","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/ajt.14266","article-title":"Novel application of localized nanodelivery of anti-interleukin-6 protects organ transplant from ischemia-reperfusion injuries","volume":"17","author":"Solhjou","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b0955","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/acsnano.9b05115","article-title":"Nanodelivery of mycophenolate mofetil to the organ improves transplant vasculopathy","volume":"13","author":"Uehara","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115429_b0960","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2024.115429_b0965","doi-asserted-by":"crossref","first-page":"L504","DOI":"10.1152\/ajplung.2000.278.3.L504","article-title":"Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody","volume":"278","author":"Li","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.addr.2024.115429_b0970","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-bioeng-121219-024239","article-title":"Red blood cell hitchhiking: A novel approach for vascular delivery of nanocarriers","volume":"23","author":"Brenner","year":"2021","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.addr.2024.115429_b0975","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2017.05.006","article-title":"Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes","volume":"188","author":"Ayenehdeh","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.addr.2024.115429_b0980","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1038\/s41598-022-09150-8","article-title":"Local induction of regulatory T cells prevents inflammatory bone loss in ligature-induced experimental periodontitis in mice","volume":"12","author":"Greene","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2024.115429_b0985","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1038\/s41598-017-17869-y","article-title":"TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model","volume":"7","author":"Ratay","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2024.115429_b0990","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2012.01.013","article-title":"Controlled release formulations of IL-2, TGF-\u03b21 and rapamycin for the induction of regulatory T cells","volume":"159","author":"Jhunjhunwala","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115429_b0995","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2017.07.006","article-title":"In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis","volume":"261","author":"Balmert","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_b1000","doi-asserted-by":"crossref","first-page":"e0239396","DOI":"10.1371\/journal.pone.0239396","article-title":"TRI microparticles prevent inflammatory arthritis in a collagen-induced arthritis model","volume":"15","author":"Bassin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115429_b1005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/B978-0-12-818731-9.00068-9","article-title":"Immunosuppressive drugs","author":"Hussain","year":"2022","journal-title":"Encyclopedia of Infection and Immunity."},{"key":"10.1016\/j.addr.2024.115429_b1010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081850","article-title":"Recruitment and expansion of tregs cells in the tumor environment\u2014how to target them?","volume":"13","author":"Cinier","year":"2021","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.addr.2024.115429_b1015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20041709","article-title":"Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor","volume":"201","author":"Lee","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.addr.2024.115429_b1020","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI43048","article-title":"Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets","volume":"121","author":"Montane","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2024.115429_b1025","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1002\/adma.201202513","article-title":"Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo","volume":"24","author":"Jhunjhunwala","year":"2012","journal-title":"Adv Mater"},{"key":"10.1016\/j.addr.2024.115429_b1030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction \u2014 A comparative study of human clinical-applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.addr.2024.115429_b1035","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1039\/C3TB21460E","article-title":"Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres","volume":"2","author":"Lewis","year":"2014","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.addr.2024.115429_b1040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.addr.2024.115429_b1045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040263","article-title":"A comprehensive map of FDA-approved pharmaceutical products","volume":"10","author":"Zhong","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_b1050","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.283.18.2445","article-title":"Payment for immunosuppression after organ transplantation","volume":"283","author":"Kasiske","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2024.115429_b1055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.addr.2024.115429_b1060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20001021","article-title":"Estimating the precursor frequency of naive antigen-specific CD8 T cells","volume":"195","author":"Blattman","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.addr.2024.115429_b1065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MOT.0000000000000218","article-title":"T-cell alloreactivity and transplantation outcome: a budding role for heterologous immunity?","volume":"20","author":"van den Heuvel","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.addr.2024.115429_b1070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1600-065X.2003.00081.x","article-title":"Crossing the bridge: large animal models in translational transplantation research","volume":"196","author":"Kirk","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.addr.2024.115429_b1075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1600-065X.2003.00082.x","article-title":"Heterologous immunity: an overlooked barrier to tolerance","volume":"196","author":"Adams","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.addr.2024.115429_b1080","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI18926","article-title":"Tolerance: Of mice and men","volume":"111","author":"Sachs","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2024.115429_b1085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687715","article-title":"Humanized mouse model as a novel approach in the assessment of human allogeneic responses in organ transplantation","volume":"12","author":"Ajith","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2024.115429_b1090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ajt.13520","article-title":"Humanized mouse models for transplant immunology","volume":"16","author":"Kenney","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_b1095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-2427(02)00045-4","article-title":"T-helper cells from naive to committed","volume":"87","author":"Saalm\u00fcller","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.addr.2024.115429_b1100","article-title":"Clinical trials for immunosuppression in transplantation: The case for reform and change in direction","volume":"101","author":"O\u2019Connell","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_b1105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: An industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115429_b1110","first-page":"72","article-title":"Current progress on biological evaluation for medical devices","volume":"45","author":"Liu","year":"2021","journal-title":"Zhongguo Yi Liao Qi Xie Za Zhi"},{"key":"10.1016\/j.addr.2024.115429_b1115","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1016\/j.biomaterials.2004.01.061","article-title":"Biocompatibility of poly(\u03b5-caprolactone)\/poly(ethylene glycol) diblock copolymers with nanophase separation","volume":"25","author":"Hsu","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115429_b1120","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/707863","article-title":"Surface modification of biomaterials: A quest for blood compatibility","volume":"2012","author":"de Mel","year":"2012","journal-title":"Int J Biomater"},{"key":"10.1016\/j.addr.2024.115429_b1125","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1021\/am5017792","article-title":"Enhanced biocompatibility of PLGA nanofibers with gelatin\/nano-hydroxyapatite bone biomimetics incorporation","volume":"6","author":"Li","year":"2014","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.addr.2024.115429_b1130","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jbm.b.34842","article-title":"Biological compatibility, thermal and in vitro simulated degradation for poly(p-dioxanone)\/poly(lactide-co-glycolide)\/poly(ethylene succinate-co-glycolide)","volume":"109","author":"Zhong","year":"2021","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.addr.2024.115429_b1135","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s11095-009-9855-9","article-title":"Immunological risk of injectable drug delivery systems","volume":"26","author":"Jiskoot","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.addr.2024.115429_b1140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40259-020-00465-4","article-title":"Immunogenicity challenges associated with subcutaneous delivery of therapeutic proteins","volume":"35","author":"Jarvi","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2024.115429_b1145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2012.02.005","article-title":"Interactions between solubilized polymer molecules and blood components","volume":"160","author":"Liu","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115429_b1150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/btm2.10063","article-title":"Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine","volume":"2","author":"Andorko","year":"2017","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.addr.2024.115429_b1155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1557\/mrs.2013.310","article-title":"Materials that harness and modulate the immune system","volume":"39","author":"Lewis","year":"2014","journal-title":"MRS Bull"},{"key":"10.1016\/j.addr.2024.115429_b1160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40139-021-00227-z","article-title":"Toxicology of nanoparticles in drug delivery","volume":"9","author":"Sharma","year":"2021","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.addr.2024.115429_b1165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/acs.chas.3c00008","article-title":"Toxicity of polymeric nanodrugs as drug carriers","volume":"30","author":"Sairam","year":"2023","journal-title":"ACS Chemical Health & Safety"},{"key":"10.1016\/j.addr.2024.115429_b1170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpb.2021.02.010","article-title":"Recent update of toxicity aspects of nanoparticulate systems for drug delivery","volume":"161","author":"Patnaik","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2024.115429_b1175","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.addr.2012.07.005","article-title":"A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines","volume":"64","author":"Szebeni","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115429_b1180","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.drudis.2018.01.025","article-title":"Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?","volume":"23","author":"Szebeni","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.addr.2024.115429_b1185","doi-asserted-by":"crossref","DOI":"10.3390\/polym15224407","article-title":"Application of the quality by design concept (QbD) in the development of hydrogel-based drug delivery systems","volume":"15","author":"Mohseni-Motlagh","year":"2023","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.addr.2024.115429_b1190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.addr.2024.115429_b1195","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2024.115429_b1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100048","article-title":"Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges","volume":"7","author":"Herdiana","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.addr.2024.115429_b1205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.2013.282034","article-title":"Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005\u20132012","volume":"311","author":"Downing","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2024.115429_b1210","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/ajt.13343","article-title":"Stratifying patients based on epitope mismatching: ready for primetime?","volume":"15","author":"Glotz","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115429_b1215","first-page":"100223","article-title":"First pig-to-human heart transplantation","volume":"3","author":"Wang","year":"2022","journal-title":"Innovation (cambridge (mass)"},{"key":"10.1016\/j.addr.2024.115429_b1220","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.scib.2022.08.026","article-title":"Genetically-engineered pig-to-human organ transplantation: a new beginning","volume":"67","author":"Zhang","year":"2022","journal-title":"Sci Bull (beijing)"},{"issue":"24","key":"10.1016\/j.addr.2024.115429_b1225","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1002\/smll.201301093","article-title":"Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery","volume":"9","author":"Li","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.addr.2024.115429_b1230","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1021\/nl8029114","article-title":"Targeted gold nanoparticles enable molecular CT imaging of cancer","volume":"8","author":"Popovtzer","year":"2008","journal-title":"Nano Lett"},{"key":"10.1016\/j.addr.2024.115429_b1235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nm1316","article-title":"In vivo imaging of islet transplantation","volume":"12","author":"Evgenov","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.addr.2024.115429_b1240","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2007.02120.x","article-title":"Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling","volume":"8","author":"Toso","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2024.115429_b1245","article-title":"MRI of auto-transplantation of bone marrow-derived stem-progenitor cells for potential repair of injured arteries","volume":"7","author":"Meng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115429_b1250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1039\/C0NR00493F","article-title":"Nanoparticles for cell labeling","volume":"3","author":"Bhirde","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2024.115429_b1255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2310\/7290.2011.00040","article-title":"Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations","volume":"11","author":"Henning","year":"2012","journal-title":"Mol Imaging"},{"key":"10.1016\/j.addr.2024.115429_b1260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2011.06.035","article-title":"Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds","volume":"156","author":"Choi","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_b1265","article-title":"Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review","volume":"29","author":"Hosseini","year":"2023","journal-title":"Mater Today Chem"},{"key":"10.1016\/j.addr.2024.115429_bib1266","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805018","article-title":"Immune responsive release of tacrolimus to overcome organ transplant rejection","volume":"30","author":"Wu","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.addr.2024.115429_bib1267","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080413","article-title":"A mixed thermosensitive hydrogel system for sustained delivery of tacrolimus for immunosuppressive therapy","volume":"11","author":"Lin","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115429_bib1268","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7150\/thno.22072","article-title":"Sustained release of immunosuppressant by nanoparticle-anchoring hydrogel scaffold improved the survival of transplanted stem cells and tissue regeneration","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2024.115429_bib1269","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00147-004-0790-8","article-title":"Drug delivery system using microspheres that contain tacrolimus in porcine small bowel transplantation","volume":"17","author":"Uemoto","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.addr.2024.115429_bib1270","article-title":"Abstract 23: Ultrasound-mediated on-demand release from ionically cross-linked hydrogel: New approach for targeted Immunotherapy in Vascularized Composite Allotransplantation","volume":"5","author":"Feturi","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.addr.2024.115429_bib1271","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jconrel.2021.06.020","article-title":"The impact of locally-delivered tacrolimus-releasing microspheres and polyethylene glycol-based islet surface modification on xenogeneic islet survival","volume":"336","author":"Nguyen","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115429_bib1272","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s11095-014-1340-4","article-title":"Local co-delivery of pancreatic islets and liposomal clodronate using injectable hydrogel to prevent acute immune reactions in a type 1 diabetes","volume":"31","author":"Haque","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.addr.2024.115429_bib1273","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jss.2017.05.046","article-title":"Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation","volume":"218","author":"Olariu","year":"2017","journal-title":"J Surg Res"},{"key":"10.1016\/j.addr.2024.115429_bib1274","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3727\/096368915X686779","article-title":"3D-printed drug\/cell carrier enabling effective release of cyclosporin a for xenogeneic cell-based therapy","volume":"24","author":"Song","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.addr.2024.115429_bib1275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4028\/www.scientific.net\/KEM.288-289.125","article-title":"An implantable immunosuppressive cyclosporine drug delivery system","volume":"288\u2013289","author":"Wang","year":"2005","journal-title":"Key Eng Mater"},{"key":"10.1016\/j.addr.2024.115429_bib1276","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00007890-199403270-00027","article-title":"The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome","volume":"57","author":"Freise","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2024.115429_bib1277","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1600-6143.2011.03725.x","article-title":"Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival","volume":"11","author":"Shirali","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_bib1278","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2007.07.045","article-title":"Preparation of rapamycin-loaded chitosan\/PLA nanoparticles for immunosuppression in corneal transplantation","volume":"349","author":"Yuan","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2024.115429_bib1297","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ajt.15662","article-title":"Co-localized immune protection using dexamethasone-eluting micelles in a murine islet allograft model","volume":"20","author":"Kuppan","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_bib1298","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/term.2464","article-title":"Local delivery of fingolimod from three-dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model","volume":"12","author":"Frei","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.addr.2024.115429_bib1299","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jbm.b.33862","article-title":"An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation","volume":"106","author":"Bowers","year":"2018","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.addr.2024.115429_bib1300","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.2337\/db16-0320","article-title":"Biopatterned CTLA4\/Fc matrices facilitate local immunomodulation, engraftment, and glucose homeostasis after pancreatic islet transplantation","volume":"65","author":"Zhang","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.addr.2024.115429_bib1301","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actbio.2016.08.015","article-title":"TGF-\u03b2 affinity-bound to a macroporous alginate scaffold generates local and peripheral immunotolerant responses and improves allocell transplantation","volume":"45","author":"Orr","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.addr.2024.115429_bib1302","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2015.11.065","article-title":"Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115429_bib1303","article-title":"Immunosuppressive PLGA TGF-\u03b21 microparticles induce polyclonal and antigen-specific regulatory T cells for local immunomodulation of allogeneic islet transplants","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.addr.2024.115429_bib1304","first-page":"1","article-title":"Evaluation of biomaterial scaffold delivery of IL-33 as a localized immunomodulatory agent to support cell transplantation in adipose tissue","volume":"1","author":"Liu","year":"2018","journal-title":"J Immunol Regen Med"},{"key":"10.1016\/j.addr.2024.115429_bib1305","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1172\/JCI133008","article-title":"Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.addr.2024.115429_bib1306","doi-asserted-by":"crossref","first-page":"120419","DOI":"10.1016\/j.biomaterials.2020.120419","article-title":"Immuno-suppressive hydrogels enhance allogeneic MSC survival after transplantation in the injured brain","volume":"266","author":"Alvarado-Velez","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115429_bib1307","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41563-018-0099-0","article-title":"Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance","volume":"17","author":"Headen","year":"2018","journal-title":"Nat Mater"},{"key":"10.1016\/j.addr.2024.115429_bib1308","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biomaterials.2018.11.015","article-title":"Localized immune tolerance from FasL-functionalized PLG scaffolds","volume":"192","author":"Skoumal","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115429_bib1309","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ajt.13049","article-title":"Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression","volume":"15","author":"Chen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.addr.2024.115429_bib1310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.015","article-title":"Localized delivery of immunosuppressive regulatory T cells to peripheral nerve allografts promotes regeneration of branched segmental defects","volume":"209","author":"Santos Roballo","year":"2019","journal-title":"Biomaterials"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24002515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24002515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T07:11:28Z","timestamp":1726297888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X24002515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":280,"alternative-id":["S0169409X24002515"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115429","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115429"}}